These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11075618)

  • 21. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
    Kisiel E; Kryczka W
    Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological aspects of antiphospholipid antibody syndrome.
    Levine SR; Brey RL
    Lupus; 1996 Oct; 5(5):347-53. PubMed ID: 8902759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiphospholipid syndrome and the kidney diseases].
    Majdan M
    Pol Merkur Lekarski; 2010 May; 28(167):341-4. PubMed ID: 20568393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.
    Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D
    Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered.
    Islam MA; Alam F; Kamal MA; Wong KK; Sasongko TH; Gan SH
    CNS Neurol Disord Drug Targets; 2016; 15(10):1253-1265. PubMed ID: 27658514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological presentations of the antiphospholipid syndrome: three illustrative cases.
    De Maeseneire Ch; Duray MC; Rutgers MP; Gille M
    Acta Neurol Belg; 2014 Jun; 114(2):117-23. PubMed ID: 24464766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex movement disorders in primary antiphospholipid syndrome: a case report.
    Carecchio M; Comi C; Varrasi C; Stecco A; Sainaghi PP; Bhatia K; Carriero A; Cantello R; Monaco F
    J Neurol Sci; 2009 Jun; 281(1-2):101-3. PubMed ID: 19344915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac manifestations in antiphospholipid syndrome.
    Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
    Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antiphospholipid (Hughes') syndrome: changing the face of neurology.
    Lampropoulos CE; Hughes GR
    Eur J Intern Med; 2004 Jun; 15(3):147-150. PubMed ID: 15245715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
    Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
    Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid syndrome and recurrent thrombosis in children.
    Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
    Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
    Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
    Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid syndromes in infectious diseases.
    Amin NM
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):131-43, vii-viii. PubMed ID: 18207071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.